Fujitec Co., Ltd. (TYO:6406)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	440,187	460,996	295,970	256,066	256,074	191,251
Market Cap Growth	44.30%	55.76%	15.58%	-0.00%	33.89%	69.57%
Enterprise Value	377,369	406,497	239,261	209,599	200,369	144,786
Last Close Price	5640.00	5907.00	3682.40	3060.28	2862.61	2093.58
PE Ratio	30.41	31.76	16.60	30.37	23.63	20.59
Forward PE	24.14	16.13	16.13	16.13	16.13	16.13
PS Ratio	1.82	1.91	1.29	1.23	1.37	1.13
PB Ratio	2.71	2.70	1.79	1.78	1.82	1.53
P/TBV Ratio	3.09	3.08	2.08	2.09	2.12	1.78
P/FCF Ratio	-	49.91	-	-	38.89	10.26
P/OCF Ratio	-	29.93	-	-	26.01	8.88
EV/Sales Ratio	1.56	1.69	1.04	1.01	1.07	0.85
EV/EBITDA Ratio	17.88	19.47	12.42	13.90	11.83	8.65
EV/EBIT Ratio	23.01	25.14	16.43	18.97	14.73	10.90
EV/FCF Ratio	-	44.01	-	-	30.43	7.77
Debt / Equity Ratio	0.03	0.03	0.04	0.07	0.03	0.03
Debt / EBITDA Ratio	-	0.21	0.30	0.65	0.23	0.19
Debt / FCF Ratio	-	0.46	-	-	0.59	0.17
Asset Turnover	-	0.93	0.94	0.92	0.88	0.85
Inventory Turnover	-	8.82	8.71	9.26	8.47	6.73
Quick Ratio	1.88	1.92	1.92	1.64	1.87	1.69
Current Ratio	2.19	2.24	2.26	1.99	2.19	2.02
Return on Equity (ROE)	-	7.47%	-	6.63%	9.00%	8.73%
Return on Assets (ROA)	-	3.90%	-	3.06%	3.99%	4.17%
Return on Capital (ROIC)	-	5.84%	-	4.63%	6.23%	6.61%
Return on Capital Employed (ROCE)	9.80%	9.20%	8.50%	7.40%	9.30%	10.10%
Earnings Yield	3.29%	3.15%	6.02%	3.29%	4.23%	4.86%
FCF Yield	-	2.00%	-	-2.37%	2.57%	9.74%
Dividend Yield	3.19%	2.79%	2.31%	2.29%	2.44%	2.87%
Payout Ratio	-	104.76%	-	76.06%	48.69%	43.64%
Buyback Yield / Dilution	0.01%	-0.03%	1.33%	2.65%	-0.14%	-0.14%
Total Shareholder Return	3.20%	2.77%	3.63%	4.93%	2.30%	2.73%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.